These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14718412)

  • 1. Long-acting bronchodilators are the first-choice option for the treatment of stable COPD.
    Cazzola M; Matera MG
    Chest; 2004 Jan; 125(1):9-11. PubMed ID: 14718412
    [No Abstract]   [Full Text] [Related]  

  • 2. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
    Reddy CB; Kanner RE
    Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA; Donohue JF
    Proc Am Thorac Soc; 2007 Oct; 4(7):526-34. PubMed ID: 17878465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of medications when treating stable COPD.
    Vestbo J
    Clin Respir J; 2010 Oct; 4(4):195-6. PubMed ID: 20887340
    [No Abstract]   [Full Text] [Related]  

  • 7. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
    Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
    COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
    Cazzola M; Matera MG
    Pulm Pharmacol Ther; 2003; 16(4):197-201. PubMed ID: 12850121
    [No Abstract]   [Full Text] [Related]  

  • 9. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of long-acting bronchodilators in the management of stable COPD.
    Tashkin DP; Cooper CB
    Chest; 2004 Jan; 125(1):249-59. PubMed ID: 14718448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease.
    Currie GP; Rossiter C; Miles SA; Lee DK; Dempsey OJ
    Pulm Pharmacol Ther; 2006; 19(2):112-9. PubMed ID: 15970450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled long-acting β-agonists versus anticholinergics in older patients with chronic obstructive pulmonary disease.
    Fabbri LM; Vogelmeier C; Rabe KF
    Ann Intern Med; 2011 Oct; 155(8):561; author reply 561-2. PubMed ID: 22007051
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
    Cazzola M; Beeh KM; Price D; Roche N
    Pulm Pharmacol Ther; 2015 Apr; 31():68-78. PubMed ID: 25727846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
    Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arformoterol (Brovana) for COPD.
    Med Lett Drugs Ther; 2007 Jul; 49(1264):53-5. PubMed ID: 17595597
    [No Abstract]   [Full Text] [Related]  

  • 17. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
    Cazzola M; Molimard M
    Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic responses in asthma and COPD. Bronchodilators.
    Donohue JF
    Chest; 2004 Aug; 126(2 Suppl):125S-137S; discussion 159S-161S. PubMed ID: 15302773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes.
    Yohannes AM; Willgoss TG; Vestbo J
    Respir Care; 2011 Apr; 56(4):477-87. PubMed ID: 21255503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New options for bronchodilator treatment in COPD.
    Calverley PM
    Thorax; 2010 Jun; 65(6):468-9. PubMed ID: 20522838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.